Clinical Trial Update: Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update of gemcitabine plus pemetrexed disodium in unresectable or metastatic biliary tract cancers, including gallbladder cancer. The study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• Gemcitabine (Gemzar) (gemcitabine)
• Pemetrexed disodium (Alimta) (pemetrexed disodium)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 1, Phase 2 | Status: COMPLETED